Axitinib, 100 mg

Axitinib is characterized by a well-defined molecular structure, belonging to the class of benzamides. Its molecular formula is C16H15N3O3, with a molecular weight of 301.3 g/mol. This compound is a potent inhibitor of multiple tyrosine kinases, including vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR). It is supplied in a pure form, with a purity level of 99%, as 100 mg tablets. Axitinib has been extensively studied in the treatment of renal cell carcinoma and other types of cancer. It exhibits strong antiproliferative activity against various tumor cells, making it an important tool in cancer research and therapy.

• CAS Number: 319460-85-0